Published in Stem Cells on October 01, 2012
Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med (2015) 1.76
CD13 regulates anchorage and differentiation of the skeletal muscle satellite stem cell population in ischemic injury. Stem Cells (2014) 0.87
A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss. EMBO Mol Med (2016) 0.85
Enter the matrix: shape, signal and superhighway. FEBS J (2013) 0.84
Muscle development, regeneration and laminopathies: how lamins or lamina-associated proteins can contribute to muscle development, regeneration and disease. Cell Mol Life Sci (2012) 0.83
Satellite cells from dystrophic muscle retain regenerative capacity. Stem Cell Res (2014) 0.82
Dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy. Skelet Muscle (2014) 0.82
The effect of the muscle environment on the regenerative capacity of human skeletal muscle stem cells. Skelet Muscle (2015) 0.81
Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy. Skelet Muscle (2016) 0.80
Prenatal muscle development in a mouse model for the secondary dystroglycanopathies. Skelet Muscle (2016) 0.77
Muscle PGC-1α modulates satellite cell number and proliferation by remodeling the stem cell niche. Skelet Muscle (2016) 0.77
Muscle Satellite Cells: Exploring the Basic Biology to Rule Them. Stem Cells Int (2016) 0.76
The altered fate of aging satellite cells is determined by signaling and epigenetic changes. Front Genet (2015) 0.75
Genome Editing and Muscle Stem Cells as a Therapeutic Tool for Muscular Dystrophies. Curr Stem Cell Rep (2017) 0.75
Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol (1961) 11.41
Pax7 is required for the specification of myogenic satellite cells. Cell (2000) 9.88
Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell (2005) 7.15
Direct isolation of satellite cells for skeletal muscle regeneration. Science (2005) 6.59
Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature (1992) 6.37
Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development (2011) 3.97
An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development (2011) 3.54
Dystroglycanopathies: coming into focus. Curr Opin Genet Dev (2011) 2.75
Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers. Dev Biol (1994) 2.55
Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J Cell Sci (2000) 2.54
Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Nat Genet (2001) 2.52
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet (2001) 2.45
Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell (2010) 2.43
Laminin polymerization induces a receptor-cytoskeleton network. J Cell Biol (1999) 2.36
Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell (2002) 2.01
Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies. Am J Hum Genet (2009) 1.83
A transitional extracellular matrix instructs cell behavior during muscle regeneration. Dev Biol (2010) 1.73
A dystroglycan mutation associated with limb-girdle muscular dystrophy. N Engl J Med (2011) 1.67
Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome. Hum Genet (2007) 1.51
The regenerative response of single mature muscle fibers isolated in vitro. Dev Biol (1975) 1.49
Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci (1989) 1.48
Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc Natl Acad Sci U S A (2009) 1.47
MyoD and myogenin are coexpressed in regenerating skeletal muscle of the mouse. Dev Dyn (1992) 1.41
Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology (2001) 1.41
Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle - eye - brain disorders. Hum Mol Genet (2002) 1.36
Abnormal glycosylation of dystroglycan in human genetic disease. Biochim Biophys Acta (2009) 1.34
Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection. Proc Natl Acad Sci U S A (2011) 1.32
Alternative splice variants of alpha 7 beta 1 integrin selectively recognize different laminin isoforms. J Biol Chem (2001) 1.25
Physical and functional association of human protein O-mannosyltransferases 1 and 2. J Biol Chem (2006) 1.22
Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies. Curr Opin Neurol (2011) 1.21
Impaired regeneration of dystrophin-deficient muscle fibers is caused by exhaustion of myogenic cells. Braz J Med Biol Res (2002) 1.15
Sparks, signals and shock absorbers: how dystrophin loss causes muscular dystrophy. Trends Cell Biol (2006) 1.14
Antagonistic effects of laminin and fibronectin on the expression of the myogenic phenotype. Differentiation (1989) 1.13
The muscle satellite cell at 50: the formative years. Skelet Muscle (2011) 1.13
Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function. FEBS Lett (2005) 1.12
Self-renewal of the adult skeletal muscle satellite cell. Cell Cycle (2005) 1.10
Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. J Pharmacol Exp Ther (2011) 1.10
Laminin-111 restores regenerative capacity in a mouse model for alpha7 integrin congenital myopathy. Am J Pathol (2008) 1.08
The muscle stem cell niche: regulation of satellite cells during regeneration. Tissue Eng Part B Rev (2008) 1.06
Satellite cell senescence underlies myopathy in a mouse model of limb-girdle muscular dystrophy 2H. J Clin Invest (2012) 1.04
Extracellular matrix components direct porcine muscle stem cell behavior. Exp Cell Res (2009) 1.03
Decorin and biglycan expression is differentially altered in several muscular dystrophies. Brain (2005) 1.01
Comparison between the growth pattern of cell cultures from normal and Duchenne dystrophy muscle. J Neurol Sci (1984) 1.01
Mature adult dystrophic mouse muscle environment does not impede efficient engrafted satellite cell regeneration and self-renewal. Stem Cells (2009) 1.00
Mutation of Large, which encodes a putative glycosyltransferase, in an animal model of muscular dystrophy. Biochim Biophys Acta (2002) 0.97
Sequential association of myogenic regulatory factors and E proteins at muscle-specific genes. Skelet Muscle (2011) 0.95
Elevated satellite cell number in Duchenne muscular dystrophy. Cell Tissue Res (2010) 0.93
Potentiation of myoblast transplantation by host muscle irradiation is dependent on the rate of radiation delivery. Cell Tissue Res (1999) 0.93
Myodystrophy, a new myopathy on chromosome 8 of the mouse. J Hered (1976) 0.92
Human myoblast engraftment is improved in laminin-enriched microenvironment. Transplantation (2008) 0.92
A comparative analysis of collagen III, IV, laminin and fibronectin in Duchenne muscular dystrophy biopsies and cell cultures. Eur J Cell Biol (1986) 0.91
Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro. Mech Dev (2008) 0.89
Impaired muscle differentiation in explant cultures of Duchenne muscular dystrophy. Lab Invest (1984) 0.85
Ahnak1 abnormally localizes in muscular dystrophies and contributes to muscle vesicle release. J Muscle Res Cell Motil (2011) 0.82
Severe muscle-eye-brain disease is associated with a homozygous mutation in the POMGnT1 gene. Eur J Paediatr Neurol (2007) 0.80
Mouse myodystrophy (myd) mutation: refined mapping in an interval flanked by homology with distal human 4q. Muscle Nerve Suppl (1995) 0.80
Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell (2005) 7.15
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol (2009) 5.35
Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain (2007) 2.88
Dystroglycanopathies: coming into focus. Curr Opin Genet Dev (2011) 2.75
Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet (2003) 2.69
Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts. Proc Natl Acad Sci U S A (2003) 2.65
A mutation in the thyroid hormone receptor alpha gene. N Engl J Med (2011) 2.62
Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol (2003) 2.47
Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathy. Nat Genet (2005) 2.38
tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia. Nat Genet (2008) 2.28
Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci U S A (2007) 2.25
Ullrich congenital muscular dystrophy: connective tissue abnormalities in the skin support overlap with Ehlers-Danlos syndromes. Am J Med Genet A (2005) 2.16
Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling. Nat Genet (2013) 2.11
Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am J Hum Genet (2007) 2.06
Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry (2012) 2.05
Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human. Neuromuscul Disord (2007) 2.03
Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol (2009) 2.03
A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells (2007) 2.03
Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet (2003) 1.94
Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain (2013) 1.93
ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat Genet (2012) 1.93
Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging (2007) 1.91
Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine. Ann Neurol (2010) 1.80
Muscular dystrophies. Lancet (2013) 1.79
Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin. Genomics (2002) 1.75
Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration. J Cell Sci (2008) 1.68
A dystroglycan mutation associated with limb-girdle muscular dystrophy. N Engl J Med (2011) 1.67
The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol (2003) 1.64
Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy. Hum Mol Genet (2005) 1.61
Identification of 45 novel mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Hum Mutat (2006) 1.61
Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations. Neurology (2013) 1.61
SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function. Science (2013) 1.57
Genotype-phenotype correlations in nemaline myopathy caused by mutations in the genes for nebulin and skeletal muscle alpha-actin. Neuromuscul Disord (2004) 1.52
Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain (2007) 1.52
Brain involvement in muscular dystrophies with defective dystroglycan glycosylation. Ann Neurol (2008) 1.52
Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia. Am J Hum Genet (2013) 1.51
Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome. Hum Genet (2007) 1.51
Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. Am J Hum Genet (2013) 1.50
Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. Brain (2012) 1.50
Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice. Mol Ther (2010) 1.48
Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan. Am J Hum Genet (2013) 1.47
Mutations in KLHL40 are a frequent cause of severe autosomal-recessive nemaline myopathy. Am J Hum Genet (2013) 1.46
Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy. Neuromuscul Disord (2005) 1.46
Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. J Clin Invest (2008) 1.46
Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am J Hum Genet (2002) 1.46
Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol (2003) 1.44
Gene expression profiling identifies molecular pathways associated with collagen VI deficiency and provides novel therapeutic targets. PLoS One (2013) 1.44
The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy. Mol Ther (2010) 1.38
Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart. J Thorac Cardiovasc Surg (2002) 1.37
Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles. Dev Biol (2009) 1.37
Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle - eye - brain disorders. Hum Mol Genet (2002) 1.36
Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J Cell Sci (2006) 1.34
Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. Curr Opin Pharmacol (2008) 1.34
Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells (2005) 1.34
Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials. Neuromuscul Disord (2010) 1.34
Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J Clin Invest (2010) 1.33
Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Dev Med Child Neurol (2011) 1.32
Defective glycosylation in congenital muscular dystrophies. Curr Opin Neurol (2004) 1.32
Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy. Physiother Res Int (2011) 1.31
Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice. PLoS One (2011) 1.31
Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy. Mol Ther (2011) 1.30
Investigating the mechanism of chromosomal deletion: characterization of 39 deletion breakpoints in introns 47 and 48 of the human dystrophin gene. Genomics (2002) 1.30
Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord (2007) 1.28
A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity. Brain Pathol (2008) 1.27
Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Ann Neurol (2003) 1.26
Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies. Glycobiology (2005) 1.25
Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability. Ann Neurol (2012) 1.25
Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations. Neuromuscul Disord (2010) 1.24
Release of reactive oxygen and nitrogen species from contracting skeletal muscle cells. Free Radic Biol Med (2004) 1.24
Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol (2010) 1.22
Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy. Ann Neurol (2006) 1.22
Are human and mouse satellite cells really the same? J Histochem Cytochem (2010) 1.21
Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research. Neuromuscul Disord (2002) 1.21
Antisense oligonucleotide-mediated exon skipping for Duchenne muscular dystrophy: progress and challenges. Curr Gene Ther (2012) 1.21
Functional requirements for fukutin-related protein in the Golgi apparatus. Hum Mol Genet (2002) 1.21
Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies. Curr Opin Neurol (2011) 1.21
Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei. Eur J Hum Genet (2009) 1.20
Identification of KLHL41 Mutations Implicates BTB-Kelch-Mediated Ubiquitination as an Alternate Pathway to Myofibrillar Disruption in Nemaline Myopathy. Am J Hum Genet (2013) 1.20
Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle. Neuromuscul Disord (2003) 1.20
What's new in neuromuscular disorders? The congenital myopathies. Eur J Paediatr Neurol (2003) 1.20
Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol (2004) 1.20